Adults with this condition may experience a wide range of symptoms, such as a lack of focus, disorganisation, and ...

Prescriptions for drugs to treat attention deficit hyperactivity disorder (ADHD) have increased 18% each year since the Covid ...

ADHD prescriptions in England have surged 18% annually since the pandemic, highlighting a major shift in diagnosis and ...

Attention deficit hyperactivity disorder (ADHD) prescriptions in England have surged by 18% annually, with sharp regional ...

Researchers analysed data on five licensed ADHD medications in England ... along with non-stimulants like atomoxetine and guanfacine. Findings indicated that methylphenidate was the most ...

Prescriptions for drugs to treat attention deficit hyperactivity disorder (ADHD) have jumped 18% year-on-year since the ...

Prescriptions for attention deficit hyperactivity disorder (ADHD) in England have risen 18% year on year since the pandemic.

atomoxetine and guanfacine. The study revealed that national ADHD prescriptions had risen from 25 per 1,000 people in 2019/2020 to 44.55 prescriptions in 2023/2024. However, there were also ...

Prescriptions for attention deficit hyperactivity disorder (ADHD) in England have risen 18% year on year since the pandemic.

Prescriptions for drugs to treat attention deficit hyperactivity disorder (ADHD ... and two non-stimulants - atomoxetine and guanfacine. The study found that methylphenidate remained the most ...